Skip to main content

How much does Daklinza cost?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on Feb 20, 2023.

Official answer


When Daklinza (daclatasvir) was on the market, the wholesale cost for a 12-week course was roughly $63,000, but patients paid a range of $72,000 to $75,000. Daklinza and the generic daclatasvir was discontinued by Bristol Myers Squibb in 2019 due to business reasons.

Daklinza (daclatasvir) was formerly approved for the treatment of chronic hepatitis C virus (HCV) in adults, in combination with sofosbuvir (brand name: Sovaldi), with or without ribavirin, in genotypes 1 and 3, including hard to treat HCV patients such as those with HIV-1 co-infection, advanced cirrhosis, or post-liver transplant recurrence of HCV.

Daklinza is classified as a HCV NS5A inhibitor.


Related medical questions

Drug information

Related support groups